Subheading · Chapter 29 · Heading 2934
2934.99: Nucleic acids and their salts, whether or not chemically: other, other
Other heterocyclic compounds
Official description Other
2934.99 is the HS subheading for other heterocyclic compounds, under heading 2934 in chapter 29.
What you pay
Importing into UK
Rates by national line · UK Global Tariff
UK lines →- 2934 99 00 00 Other
- 2934 99 60 00 Chlorprothixene (inn); thenalidine (inn) and its tartrates and maleates; furazolidone (inn); 7-aminocephalosporanic acid; salts and esters of (6r,7r)-3-acetoxymethyl-7-[(r)-2-formyloxy-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1.3-dioxan-2-yl)ethyl]-2-methylpyridinium bromide Free
- 2934 99 90 00 Other
- 2934 99 90 04 Silthiofam (iso) (cas rn 175217-20-6) with a purity by weight of 98% or more 6%
- 2934 99 90 05 (s)-2-methyl-1-(6-nitropyridin-3-yl)-4-(oxetan-3-yl)piperazine (cas rn 1895867-67-0) with a purity by weight of 97% or more 6%
- 2934 99 90 06 Cis-[2-(2.4-dichlorodiphenyl)-2-(1h-imidazol-1-ylmethyl)-1.3-dioxolan-4yl]methyl-4-methylbenzenesulfonate (cas rn 134071-44-6) with a purity by weight of 99% or more 6%
- 2934 99 90 07 Cedazuridine (inn) (cas rn 1141397-80-9) with a purity by weight of 99% or more 6%
- 2934 99 90 08 (r)-tert-butyl 2-(6-(5-chloro-2-((tetrahydro-2h-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)propanoate (cas rn 2095665-45-3) with a purity by weight of 98% or more 6%
- 2934 99 90 09 3-[2-{(2r,3s)-3-[(1r)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoyl]-4.4-dimethyl-1.3-oxazolidin-2-one (isomeric mixture of cas rns 114341-89-8 and 114418-63-2) with a purity by weight of 99% or more 6%
- 2934 99 90 10 Fluralaner (inn) (cas rn 864731-61-3) 6%
- 2934 99 90 11 Aqueous solution of d(p-thio)(t-g-a-c-t-g-t-g-a-a-c-g-t-t-c-g-a-g-a-t-g-a) deoxyribonucleic acid (cas rn 937402-51-2), containing by weight 15% or more, but not more than 25% of oligodeoxynucleotide 6%
- 2934 99 90 12 Dimethomorph (iso) (cas rn 110488-70-5) 6%
- 2934 99 90 13 (6s)-6-methyl-5.6-dihydro-4h-thieno[2.3-b]thiopyran4-one-7.7-dioxide (cas rn 148719-91-9) with a purity by weight of 98% or more 6%
- 2934 99 90 14 2-mercaptoadenosine (cas rn 43157-50-2) with a purity by weight of 98% or more 6%
- 2934 99 90 16 Difenoconazole (iso) (cas rn 119446-68-3) 6%
- 2934 99 90 17 (s)-4-(tert-butoxycarbonyl)-1.4-oxazepane-2-carboxylic acid (cas rn 1273567-44-4) with a purity by weight of 95% or more 6%
- 2934 99 90 18 Methyl (1r,3r)-1-(1.3-benzodioxol-5-yl)-2-(2-chloroacetyl)-1.3,4.9-tetrahydropyrido[5.4-b]indole-3-carboxylate (cas rn 171489-59-1) with a purity by weight of 99% or more 6%
- 2934 99 90 19 (4r,6s)-6-methyl-7.7-dioxo-5.6-dihydro-4h-thieno[2.3-b]thiopyran-4-ol (cas rn 147128-77-6) with a purity by weight of 94% or more 6%
- 2934 99 90 20 Thiophene (cas rn 110-02-1) 6%
- 2934 99 90 21 Acesulfame potassium (potassium salt of 6-methyl-1.2,3-oxathiazin-4(3h)-one 2.2-dioxide; cas rn 55589-62-3) ace-k Free
- 2934 99 90 22 4-(oxiran-2-ylmethoxy)-9h-carbazole (cas rn 51997-51-4) with a purity by weight of 97% or more 6%
- 2934 99 90 24 Flufenacet (iso) (cas rn 142459-58-3) with a purity by weight of 95% or more 6%
- 2934 99 90 26 4-methylmorpholine 4-oxide in an aqueous solution (cas rn 7529-22-8) 6%
- 2934 99 90 27 2-(4-hydroxyphenyl)-1-benzothiophene-6-ol (cas rn 63676-22-2) 6%
- 2934 99 90 28 11-(piperazin-1-yl)dibenzo[b,f][1.4]thiazepine dihydrochloride (cas rn 111974-74-4) 6%
- 2934 99 90 30 Dibenzo[b,f][1.4]thiazepin-11(10h)-one (cas rn 3159-07-7) 6%
- 2934 99 90 31 Thenoic acid (cas rn 1918-77-0) with a purity by weight of 97% or more 6%
- 2934 99 90 32 (6r,7r)-benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (cas rn 54639-48-4) with a purity by weight of 95% or more 6%
- 2934 99 90 34 Benzyl 4-(oxetan-3-yl)piperazine-1-carboxylate (cas rn 1254115-22-4) with a purity by weight of 99% or more 6%
- 2934 99 90 35 Nusinersen sodium (innm) (cas rn 1258984-36-9) with a purity by weight of 95% or more 6%
- 2934 99 90 36 Nadide phosphate (innm) disodium salt (cas rn 24292-60-2) with a purity by weight of 97% or more 6%
- 2934 99 90 37 4-propan-2-ylmorpholine (cas rn 1004-14-4) 6%
- 2934 99 90 38 2-chloro-9h-thioxanthen-9-one (cas rn 86-39-5) with a purity by weight of 98% or more 6%
- 2934 99 90 39 4-(oxiran-2-ylmethoxy)-9h-carbazole (cas rn 51997-51-4) 6%
- 2934 99 90 40 2.3-pyrazinedicarboxylic anhydride (cas rn 4744-50-7) with a purity by weight of 95% or more 6%
- 2934 99 90 41 11-[4-(2-chloro-ethyl)-1-piperazinyl]dibenzo(b,f)(1.4)thiazepine (cas rn 352232-17-8) 6%
- 2934 99 90 45 4-[4-[(5s)-5-(aminomethyl)-2-oxo-3-oxazolidinyl] phenyl]-3-morpholinone, hydrochloride (cas rn 898543-06-1) with a purity by weight of 98% or more 6%
- 2934 99 90 46 (6r-trans)-7-amino-8-oxo-3-[[(1.2,5.6-tetrahydro-2-methyl-5.6-dioxo-1.2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cas rn 58909-56-1) with a purity by weight of 97% or more 6%
- 2934 99 90 47 2.4-diethyl-9h-thioxanthen-9-one (cas rn 82799-44-8) with a purity by weight of 97% or more 6%
- 2934 99 90 48 Propan-2-ol -- 2-methyl-4-(4-methylpiperazin-1-yl)-10h-thieno[2.3-b][1.5]benzodiazepine (1:2) dihydrate, (cas rn 864743-41-9) 6%
- 2934 99 90 49 Cytidine 5'-(disodium phosphate) (cas rn 6757-06-8) 6%
- 2934 99 90 50 Vutrisiran (inn) (cas rn 1867157-35-4) with a purity by weight of 98% or more 6%
- 2934 99 90 51 Uridine 5'-triphosphate trisodium salt (cas rn 19817-92-6) with a dry weight purity of 90% or more 6%
- 2934 99 90 55 Uridine (cas rn 58-96-8) with a purity by weight of 98% or more 6%
- 2934 99 90 56 1-[5-(2.6-difluorophenyl)-4.5-dihydro-1.2-oxazol-3-yl]ethanone (cas rn 1173693-36-1) 6%
- 2934 99 90 57 Dimethenamide-p (iso) (cas rn 163515-14-8) with a purity by weight of 93% or more 6%
- 2934 99 90 59 Dolutegravir (inn) (cas rn 1051375-16-6) or dolutegravir sodium (cas rn 1051375-19-9) 6%
- 2934 99 90 60 Dl-homocysteine thiolactone hydrochloride (cas rn 6038-19-3) 6%
- 2934 99 90 61 5-(1.2-dithiolan-3-yl)valeric acid (cas rn 1077-28-7) 6%
- 2934 99 90 63 (2b,3a,5a,16b,17b)-2-(morpholin-4-yl)-16-(pyrrolidin-1-yl)androstane-3.17-diol (cas rn 119302-20-4) 6%
- 2934 99 90 64 2-bromo-5-benzoylthiophene (cas rn 31161-46-3) 6%
- 2934 99 90 65 Benzo[b]thiophen-10-methoxycycloheptanone (cas rn 59743-84-9) with a purity by weight of 98% or more 6%
- 2934 99 90 66 Tetrahydrothiophene-1.1-dioxide (cas rn 126-33-0) 6%
- 2934 99 90 67 5-chlorothiophene-2-carboxylic acid (cas rn 24065-33-6) 6%
- 2934 99 90 69 3-methyl-5-(4.4,5.5-tetramethyl-1.3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3h)-one (cas rn 1220696-32-1) with a purity by weight of 95% or more 6%
- 2934 99 90 70 1.3,4-thiadiazolidine-2.5-dithione (cas rn 1072-71-5) with a purity by weight of 95% or more 6%
- 2934 99 90 71 3.4-dichloro-1.2,5-thiadiazole (cas rn 5728-20-1) with a purity by weight of 99% or more 6%
- 2934 99 90 72 2-trifluoromethyl-9-allyl-9-thioxanthen-ol (cas rn 850808-70-7) with a purity by weight of 98% or more 6%
- 2934 99 90 74 2-isopropylthioxanthone (cas rn 5495-84-1) 6%
- 2934 99 90 75 (4r-cis)-1.1-dimethylethyl-6-[2[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrol-1-yl]ethyl]-2.2-dimethyl-1.3-dioxane-4-acetate (cas rn 125971-95-1) 6%
- 2934 99 90 76 Nedosiran sodium (innm) (cas rn 2247026-22-6) with a purity by weight of 95% or more 6%
- 2934 99 90 77 Tazemetostat (inn) (cas 1403254-99-8) with a purity by weight of 99% or more and its salts 6%
- 2934 99 90 78 Disodium uridine-5'-monophosphate (cas rn 3387-36-8) with a purity by weight of 98% or more 6%
- 2934 99 90 81 1-(4-aminophenyl)-5-(morpholin-4-yl)-2.3-dihydropyridin-6-one (cas rn 1267610-26-3) with a purity by weight of 98% or more 6%
- 2934 99 90 82 Rel-(3ar,12br)-11-chloro-2.3,3a,12b-tetrahydro-2-methyl-1h-dibenz[2.3:6.7]oxepino[4.5-c]pyrrol-1-one (cas rn 129385-59-7) with a purity by weight of 97% or more 6%
- 2934 99 90 83 Flumioxazin (iso) (cas rn 103361-09-7) of a purity by weight of 96% or more 6%
- 2934 99 90 85 Gilteritinib (inn) (cas 1254053-43-4) with a purity by weight of 98% or more and its salts 6%
- 2934 99 90 86 Dithianon (iso) (cas rn 3347-22-6) 6%
- 2934 99 90 87 2.2'-(1.4-phenylene)bis(4h-3.1-benzoxazin-4-one) (cas rn 18600-59-4) 6%
- 2934 99 90 88 (7s,9as)-7-((benzyloxy)methyl)octahydropyrazino[2.1-c][1.4]oxazine dioxalate (cas rn 1268364-46-0) 6%
- 2934 99 90 89 6r-[6α,7β(z)]]-7-[2-furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cas rn 56271-94-4) with a purity by weight of 96% or more 6%
- 2934 99 90 90 Other Free
Additional duties and import rules
Charges on top of the customs duty, and rules the goods must meet at the border.
Additional duties and charges 3
- Additional dutyAdditional duties 35%
- Applies to goods from
- Belarus, Russia
- Legal act
- 2022 No. 833
- Documents
- 9018
- Duty suspensionSuspension - goods for certain categories of ships, boats and other vessels and for drilling or production platforms Free
- Applies to goods from
- all countries
- Legal act
- 2020 No. 1431
- Documents
- C990 End use authorisation ships and platforms (Column 8c, Annex A of Delegated Regulation (EU) 2015/2446)
- Duty suspensionAutonomous tariff suspension Free
- Applies to goods from
- all countries
- In force
- until 31 December 2028
- Legal act
- 2020 No. 1435
- Documents
- 9Y12
- Tariff lines
- on 33 of 70 lines
Import requirements 4
- Prohibition or restrictionImport prohibition
- Applies to goods from
- North Korea
- Legal act
- S.I. 2019/411
- Tariff lines
- on 69 of 70 lines
- Import controlRestriction on entry into free circulation
- Applies to goods from
- Syria, Ukraine
- Legal act
- S.I. 2022/395, S.I. 2019/792
- Documents
- 9009
- 9010
- 9017
- Import controlImport control on restricted goods and technologies
- Applies to goods from
- Iran, Libya, North Korea, Russia
- Legal act
- S.I. 2019/461, S.I. 2019/411, 2020 No. 1665, S.I. 2019/855
- Documents
- Tariff lines
- on 69 of 70 lines
- Import controlHome Office Controlled Drugs (import)
- Applies to goods from
- all countries
- Legal act
- 2001 No. 3998
- Documents
- 9113
- 913Y
- Tariff lines
- on 2 of 70 lines
Preferential rates by country
| Agreement or scheme | Countries | Rate |
|---|---|---|
| standard rate (no agreement) | — | Free – 6% |
| DCTS Comprehensive | Afghanistan, Angola, Bangladesh, Benin and 38 moreAfghanistan, Angola, Bangladesh, Benin, Bhutan, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad, Comoros, Congo - Kinshasa, Djibouti, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Kiribati, Laos, Liberia, Malawi, Mali, Mauritania, Myanmar (Burma), Nepal, Niger, Rwanda, São Tomé & Príncipe, Senegal, Sierra Leone, Somalia, South Sudan, Sudan, Tanzania, Timor-Leste, Togo, Tuvalu, Uganda, Yemen, Zambia | Free |
| European Union (including code " EU") | Free | |
| DCTS Enhanced | Algeria, Bolivia, Cape Verde, Congo - Brazzaville and 13 moreAlgeria, Bolivia, Cape Verde, Congo - Brazzaville, Cook Islands, Kyrgyzstan, Micronesia, Mongolia, Nigeria, Niue, Pakistan, Philippines, Sri Lanka, Syria, Tajikistan, Uzbekistan, Vanuatu | Free |
| CARIFORUM | Antigua & Barbuda, Bahamas, Barbados, Belize and 10 moreAntigua & Barbuda, Bahamas, Barbados, Belize, Dominica, Dominican Republic, Grenada, Guyana, Jamaica, St Kitts & Nevis, St Lucia, St Vincent & the Grenadines, Suriname, Trinidad & Tobago | Free |
| OCTs (Overseas Countries and Territories) | Anguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands and 7 moreAnguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands, Cayman Islands, Falkland Islands, Montserrat, Pitcairn Islands, South Georgia & South Sandwich Islands, St Helena, Turks & Caicos Islands | Free |
| Central America | Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama | Free |
| SADC EPA | Botswana, Eswatini, Lesotho, Mozambique, Namibia | Free |
| Eastern and Southern Africa States | Madagascar, Mauritius, Seychelles, Zimbabwe | Free |
| CPTPP | Brunei, Malaysia | Free |
| UK–Andorra agreement | Andorra | Free |
| UK–Albania agreement | Albania | Free |
| UK–Australia agreement | Australia | Free |
| UK–Canada agreement | Canada | Free |
| UK–Switzerland agreement | Switzerland | Free |
| UK–Côte d’Ivoire agreement | Côte d’Ivoire | Free |
| UK–Chile agreement | Chile | Free |
| UK–Cameroon agreement | Cameroon | Free |
| UK–Colombia agreement | Colombia | Free |
| UK–Ceuta & Melilla agreement | Ceuta & Melilla | Free |
| UK–Ecuador agreement | Ecuador | Free |
| UK–Egypt agreement | Egypt | Free |
| UK–Fiji agreement | Fiji | Free |
| UK–Faroe Islands agreement | Faroe Islands | Free |
| UK–Georgia agreement | Georgia | Free |
| UK–Ghana agreement | Ghana | Free |
| DCTS Standard | Indonesia | Free |
| UK–Israel agreement | Israel | Free |
| UK–India agreement | India | Free |
| UK–Iceland agreement | Iceland | Free |
| UK–Jordan agreement | Jordan | Free |
| UK–Japan agreement | Japan | Free |
| UK–Kenya agreement | Kenya | Free |
| UK–South Korea agreement | South Korea | Free |
| UK–Lebanon agreement | Lebanon | Free |
| UK–Liechtenstein agreement | Liechtenstein | Free |
| UK–Morocco agreement | Morocco | Free |
| UK–Moldova agreement | Moldova | Free |
| UK–North Macedonia agreement | North Macedonia | Free |
| UK–Mexico agreement | Mexico | Free |
| UK–Norway agreement | Norway | Free |
| UK–New Zealand agreement | New Zealand | Free |
| UK–Peru agreement | Peru | Free |
| UK–Papua New Guinea agreement | Papua New Guinea | Free |
| UK–Palestinian Territories agreement | Palestinian Territories | Free |
| UK–Serbia agreement | Serbia | Free |
| UK–Solomon Islands agreement | Solomon Islands | Free |
| UK–Singapore agreement | Singapore | Free |
| UK–San Marino agreement | San Marino | Free |
| UK–Tunisia agreement | Tunisia | Free |
| UK–Türkiye agreement | Türkiye | Free |
| UK–Ukraine agreement | Ukraine | Free |
| UK–Vietnam agreement | Vietnam | Free |
| UK–Samoa agreement | Samoa | Free |
| UK–Kosovo agreement | Kosovo | Free |
| UK–South Africa agreement | South Africa | Free |
UK: imports by month
Main suppliers, last 12 months
| Country | Value | Share | Change |
|---|---|---|---|
| £117.4m | 26.8% | +36.5% | |
| £88.4m | 20.2% | -11.2% | |
| £75.5m | 17.3% | +44.6% | |
| £54.3m | 12.4% | -19.1% | |
| £51.7m | 11.8% | +2.8% | |
| £17.6m | 4% | -44.1% | |
| £5.6m | 1.3% | -84.8% | |
| £4.5m | 1% | -24.2% |
Same subheading in other tariffs
World trade in 2024
Trade value (US$) no reported trade < US$57kUS$57k+US$4m+US$374m+> US$2bn
Exports: 161
- Ireland: US$5bn
- China: US$4bn
- Singapore: US$3bn
- Switzerland: US$2bn
- United States: US$2bn
- Germany: US$1bn
- India: US$1bn
- Belgium: US$1bn
- Japan: US$1bn
- Spain: US$956m
- United Kingdom: US$929m
- Netherlands: US$677m
- Italy: US$470m
- France: US$416m
- South Korea: US$374m
- Austria: US$220m
- Finland: US$143m
- Slovenia: US$98m
- Lithuania: US$70m
- Indonesia: US$64m
- Taiwan: US$63m
- Hungary: US$62m
- Sweden: US$51m
- Canada: US$51m
- Czechia: US$41m
- Portugal: US$34m
- Mexico: US$31m
- Israel: US$19m
- Ukraine: US$16m
- Denmark: US$13m
- Poland: US$12m
- Argentina: US$11m
- Croatia: US$11m
- Thailand: US$9m
- Hong Kong SAR China: US$8m
- Türkiye: US$5m
- Malta: US$4m
- Brazil: US$3m
- Malaysia: US$3m
- Luxembourg: US$3m
- Russia: US$3m
- Latvia: US$2m
- South Africa: US$2m
- Greece: US$2m
- Australia: US$1m
- Uruguay: US$1m
- Slovakia: US$1m
- Romania: US$995k
- Saudi Arabia: US$841k
- Belize: US$577k
- Norway: US$554k
- Guatemala: US$542k
- Estonia: US$517k
- Serbia: US$453k
- Chile: US$444k
- Kazakhstan: US$433k
- Mauritius: US$410k
- Cyprus: US$385k
- Kyrgyzstan: US$359k
- New Zealand: US$326k
Trade value (US$) no reported trade < US$2mUS$2m+US$23m+US$382m+> US$932m
Imports: 183
- United States: US$6bn
- Germany: US$5bn
- Ireland: US$2bn
- Italy: US$1bn
- Japan: US$1bn
- Austria: US$932m
- Brazil: US$855m
- Switzerland: US$834m
- India: US$728m
- Belgium: US$688m
- France: US$688m
- Spain: US$682m
- United Kingdom: US$452m
- Canada: US$451m
- Portugal: US$447m
- Russia: US$422m
- Netherlands: US$393m
- South Korea: US$384m
- China: US$382m
- Singapore: US$238m
- Romania: US$200m
- Türkiye: US$197m
- Poland: US$178m
- Argentina: US$174m
- Mexico: US$131m
- Indonesia: US$117m
- Pakistan: US$107m
- Hungary: US$102m
- Greece: US$82m
- Taiwan: US$81m
- Vietnam: US$76m
- Australia: US$70m
- Norway: US$70m
- Thailand: US$65m
- United Arab Emirates: US$61m
- Israel: US$58m
- Denmark: US$51m
- Egypt: US$49m
- Colombia: US$49m
- Finland: US$44m
- South Africa: US$40m
- Sweden: US$37m
- Bangladesh: US$34m
- Ukraine: US$27m
- New Zealand: US$26m
- Philippines: US$23m
- Hong Kong SAR China: US$23m
- Slovenia: US$19m
- Guatemala: US$17m
- Malaysia: US$17m
- Paraguay: US$16m
- Czechia: US$16m
- Chile: US$16m
- Lithuania: US$16m
- Saudi Arabia: US$14m
- Croatia: US$14m
- Uruguay: US$13m
- Iran: US$12m
- Morocco: US$12m
- Panama: US$12m
Top exporters
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$5bn | 20.7% | |
| 2 | US$4bn | 16.3% | |
| 3 | US$3bn | 10.7% | |
| 4 | US$2bn | 8.4% | |
| 5 | US$2bn | 6.3% | |
| 6 | US$1bn | 5.7% | |
| 7 | US$1bn | 5.3% | |
| 8 | US$1bn | 4.1% | |
| 9 | US$1bn | 4% | |
| 10 | US$956m | 3.6% |
Top importers
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$6bn | 23.5% | |
| 2 | US$5bn | 19.9% | |
| 3 | US$2bn | 6.4% | |
| 4 | US$1bn | 4.1% | |
| 5 | US$1bn | 3.9% | |
| 6 | US$932m | 3.5% | |
| 7 | US$855m | 3.2% | |
| 8 | US$834m | 3.2% | |
| 9 | US$728m | 2.8% | |
| 10 | US$688m | 2.6% |
Import duty on this product around the world 164
The most-favoured-nation (MFN) duty each country applies to goods of this HS subheading: the average over its national tariff lines, with the lowest and highest line where they differ. Goods from countries with a trade agreement often pay less.
- 4.8%median duty
- 57number of duty-free countries (MFN)
- 45%highest: Bahamas, Bermuda, Cayman Islands
164
| Importing country | MFN duty | lines from – to | data year |
|---|---|---|---|
| 5% | 2018 · HS 2012 | ||
| 0% | 2023 | ||
| 15% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 10% | 2021 · HS 2017 | ||
| 5% | 2021 · HS 2007 | ||
| 5.3% | 0% – 14% | 2023 · HS 2017 | |
| 2.7% | 0% – 5% | 2023 | |
| 6% | 2021 · HS 2012 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 45% | 2022 | ||
| 5% | 2023 | ||
| 1.7% | 0% – 5% | 2023 · HS 2017 | |
| 5% | 2022 · HS 2017 | ||
| 2.7% | 0% – 5% | 2021 · HS 2017 | |
| 5% | 2023 | ||
| 5% | 2023 | ||
| 25% | 2023 | ||
| 10% | 2022 | ||
| 2.5% | 0% – 5% | 2023 · HS 2017 | |
| 0% | 2022 | ||
| 0% | 2023 | ||
| 6% | 0% – 14% | 2023 · HS 2017 | |
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 5.8% | 0% – 7% | 2023 · HS 2017 | |
| 10% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 · HS 2017 | ||
| 22% | 2021 · HS 2002 | ||
| 10% | 2023 | ||
| 10% | 2023 | ||
| 6% | 2023 · HS 2017 | ||
| 6.5% | 6% – 6.5% | 2023 | |
| 0% | 2023 · HS 2017 | ||
| 20% | 2021 · HS 2017 | ||
| 10% | 2023 | ||
| 0% | 2022 · HS 2017 | ||
| 0% | 2023 | ||
| 5% | 2023 · HS 2017 | ||
| 10% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 2% | 2019 · HS 2017 | ||
| 0% | 2022 | ||
| 10% | 2023 | ||
| 0% | 2023 | ||
| 10% | 2021 · HS 2017 | ||
| 3.3% | 0% – 6.5% | 2023 | |
| 5% | 2023 | ||
| 8% | 2023 | ||
| 10% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2022 · HS 2017 | ||
| 5% | 2023 | ||
| 12% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2012 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2023 · HS 2017 | ||
| 0% | 2020 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 7.5% | 2023 | ||
| 5% | 2023 | ||
| 9.9% | 5% – 26% | 2020 · HS 2017 | |
| 0% | 2022 · HS 2017 | ||
| 0% | 2023 | ||
| 0.5% | 0% – 1.6% | 2023 | |
| 0% | 2023 | ||
| 2.7% | 0% – 5% | 2023 | |
| 0% | 2023 | ||
| 0% | 2023 · HS 2002 | ||
| 5% | 2023 | ||
| 2.7% | 0% – 5% | 2021 · HS 2017 | |
| 5% | 2023 · HS 2017 | ||
| 5% | 2020 · HS 2017 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2021 · HS 2017 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 15% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 4.2% | 0% – 5% | 2023 · HS 2017 | |
| 4% | 2021 · HS 2017 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 · HS 2017 | ||
| 2.5% | 2023 | ||
| 2.5% | 2023 | ||
| 3% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 10% | 2021 · HS 2017 | ||
| 10% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2023 | ||
| 1.7% | 0% – 5% | 2023 | |
| 0% | 2023 | ||
| 5% | 2023 | ||
| 7.7% | 0% – 20% | 2023 | |
| 3% | 2023 · HS 2012 | ||
| 0% | 2017 · HS 2017 | ||
| 2% | 0% – 6% | 2023 | |
| 0% | 2023 | ||
| 5.2% | 0% – 14% | 2023 · HS 2017 | |
| 0% | 2023 · HS 2017 | ||
| 1% | 2023 | ||
| 5% | 2023 | ||
| 2.7% | 0% – 5% | 2021 · HS 2017 | |
| 0% | 2023 | ||
| 8% | 2020 · HS 2017 | ||
| 10% | 2019 · HS 2017 | ||
| 5% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 5.6% | 2% – 6.5% | 2023 | |
| 0% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 · HS 2012 | ||
| 8% | 2021 · HS 2017 | ||
| 5% | 2023 | ||
| 3% | 2021 · HS 2017 | ||
| 5% | 2023 · HS 2007 | ||
| 0% | 2023 | ||
| 1% | 2020 · HS 2012 | ||
| 0% | 2021 · HS 2012 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 15% | 2023 · HS 2017 | ||
| 0% | 2023 · HS 2012 | ||
| 4.3% | 0% – 6.5% | 2023 | |
| 0% | 2017 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 | ||
| 5.7% | 0% – 6% | 2023 | |
| 4.6% | 0% – 6.5% | 2023 | |
| 5.6% | 0% – 14% | 2023 · HS 2017 | |
| 0% | 2021 · HS 2017 | ||
| 5% | 2023 | ||
| 5.5% | 0% – 14% | 2023 · HS 2017 | |
| 4.2% | 0% – 10% | 2023 | |
| 6% | 2021 · HS 2012 | ||
| 5% | 2017 · HS 2017 | ||
| 7.5% | 0% – 15% | 2023 | |
| 0.1% | 2023 |
Tariff data years 2017–2023; rates may have changed since. · UNCTAD TRAINS, accessed via WITS (World Bank)
Classifications and correspondences
Where this HS subheading sits in the United Nations' statistical classifications, and which codes it had in earlier editions of the Harmonized System.
- SITC Rev. 4
- 51579 Heterocyclic compounds, n.e.s.
- End use (BEC Rev. 5)
- Intermediate goods · BEC 211220
- CPC 2.1 product
- 34160 Organo-sulphur compounds and other organo-inorganic compounds; heterocyclic compounds n.e.c.; nucleic acids and their salts
- ISIC Rev. 4 activity
- 2011 Manufacture of basic chemicals
Earlier HS editions
| HS | Code | |
|---|---|---|
| 2017 | 2934.99 | changed |
| 2012 | 2934.99 | changed |
| 2007 | 2934.99 | changed |
| 2002 | 2934.99 | changed |
| 1996 | 2934.90 | changed |
| 1992 | 2933.59, 2934.90 | changed |
Correspondence tables of the United Nations Statistics Division (UNSD)
Binding rulings for similar goods 47
Decisions of U.S. Customs and Border Protection (CROSS) and HMRC (Advance Tariff Rulings) on goods classified here. A ruling binds only its holder, but shows how the authorities classify similar goods. The descriptions are the authorities’ own, in English.
- N364523 U.S. CBP
The tariff classification of Suzetrigine (CAS No. 2649467-58-1) imported in bulk powder form, from India
- N357497 U.S. CBP
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
- N354921 U.S. CBP
The tariff classification of Terazosin Hydrochloride Anhydrous (CAS No. 63074-08-8) in bulk form, from Germany
- N353870 U.S. CBP
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
- N351608 U.S. CBP
The tariff classification of RVU305 in bulk form, from China
- N343643 U.S. CBP
The tariff classification of Deoxyribonucleic Acid Sodium Salt (DNA-Na) from Japan
- 600011586 HMRC
DNA is a double-stranded molecule forming a double helix. Each strand is made up of nucleotides, which include a phosphate group, a sugar molecule (deoxyribose), and one of four nitrogenous bases: adenine (A), thymine (T), cytosine ©, and guanine (G). RNA is typically single-stranded and shorter…
- 600010728 HMRC
PolyIC Polyinosinic Acid, sodium salt - a double strand RNA Use: in the treatment of neoplastic diseases Packaging: 10ml sterile glass vial. Transport is frozen at -78°C
- 600010731 HMRC
nucleic acid samples RNA (ribonucleic acid) and DNA (deoxyribonucleic acid) Used for clinical trials, laboratory research or diagnostic use Packaging: in test tubes or slides
47 rulings in total for this code
Recent rule changes mentioning this code
Acts whose text cites this code or its heading. Check the act itself: a code can be cited for reasons other than a change of its duty.
-
FR Doc. 2026-21767 · 91 FR 67290 · Source: federalregister.gov
-
FR Doc. 2026-20286 · 91 FR 63307 · Source: federalregister.gov
-
FR Doc. 2026-19498 · 91 FR 60360 · Source: federalregister.gov
-
FR Doc. 2026-14542 · 91 FR 45516 · Source: federalregister.gov
-
Update to VAT S Coverage – 9 July 2026
Trade Tariff news 7160 · Source: trade-tariff.service.gov.uk
-
İthalat Rejimi Kararında Değişiklik Yapılmasına İlişkin Karar (Karar Sayısı: 11485)
RG 01.07.2026 sayı 33297 · Karar 11485 · Source: resmigazete.gov.tr
-
CELEX 32026R1463 · Source: eur-lex.europa.eu
-
CELEX 32026R1465 · Source: eur-lex.europa.eu
The UK Global Tariff divides subheading 2934.99 into 70 tariff lines; the duty is between 0% and 6% (average 5.7%). 3 of them are duty-free.
In the EU Combined Nomenclature, subheading 2934.99 covers 2 tariff lines and the duty is between 0% and 6.5%. 1 of them is duty-free.
174 countries pay no duty in the UK thanks to trade agreements and preference schemes such as DCTS Comprehensive and European Union, against a standard rate of Free – 6%.
In the UK, additional duty of 35% applies on top of the customs duty to goods from Belarus and Russia.
Imports of other heterocyclic compounds into the UK came to £437.6m between September 2025 and August 2026 (down 3% on the year before); United States supplied 27%, followed by Germany.
In 2024, countries exported other heterocyclic compounds worth US$26bn (+12.3% year on year).
The largest exporter was Ireland (US$5bn), followed by China.
Questions and answers
What is the HS code for nucleic acids and their salts, whether or not chemically: other, other?
Nucleic acids and their salts, whether or not chemically: other, other fall under HS subheading 2934.99, part of heading 2934, in section VI of the Harmonized System.
What is the import duty on nucleic acids and their salts in the UK?
Under the UK Global Tariff, imports under 2934.99 from countries without a preferential agreement are charged at 0% to 6%, depending on the line. Preferential rates, anti-dumping duties and VAT are not included.
What is the import duty on nucleic acids and their salts in the EU?
Under the EU Combined Nomenclature, imports under 2934.99 from countries without a preferential agreement are charged at 0% to 6.5%, depending on the line. Preferential rates, anti-dumping duties and VAT are not included.
Which country exports the most nucleic acids and their salts?
Ireland, with US$5bn in 2024 (20.7% of world exports).
Which countries can export other heterocyclic compounds to the UK duty-free?
174 countries pay no duty under a trade agreement or preference scheme, among them partners under DCTS Comprehensive, European Union, DCTS Enhanced. The goods must meet the agreement’s rules of origin and the importer needs proof of origin; otherwise the standard rate of Free – 6% applies. Pick a country above to see its rate.
Is there anti-dumping duty on other heterocyclic compounds?
The UK charges additional duty of 35% on goods from Belarus and Russia. Lower rates apply to the named exporters listed in the measure.
Where does the UK import other heterocyclic compounds from?
In the 12 months to August 2026, the largest suppliers were United States (27%), Germany (20%) and Switzerland (17%), out of total imports of £437.6m.